Cogent Biosciences (COGT) Amortizatization of Intangibles (2017 - 2026)

Cogent Biosciences (COGT) has 8 years of Amortizatization of Intangibles data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles rose 23.56% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 69.53% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 74.25% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $1.2 million, up from $1.1 million in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for COGT reached as high as $6.2 million in Q3 2024 and fell as low as -$2.6 million in Q2 2024.
• Historically, Amortizatization of Intangibles has averaged $1.2 million across 5 years, with a median of $1.0 million in 2023.
• On a YoY basis, Amortizatization of Intangibles climbed as much as 782.07% in 2024 and fell as far as 450.2% in 2024.
• Year by year, Amortizatization of Intangibles stood at $1.2 million in 2022, then surged by 263.96% to $4.3 million in 2023, then tumbled by 39.47% to $2.6 million in 2024, then plunged by 59.45% to $1.1 million in 2025, then increased by 11.74% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $167000.0 in Q3 2025.